[
  {
    "id": "rn-q-001",
    "scope": ["RN"],
    "medicationId": "rn-001",
    "medication": "Quinidine",
    "questionType": "multiple-choice",
    "stem": "Which assessment finding in a patient taking quinidine requires immediate notification of the provider?",
    "choices": [
      "Mild nausea",
      "Excessive diarrhea",
      "Occasional dizziness",
      "Dry mouth"
    ],
    "correctAnswer": "Excessive diarrhea",
    "rationale": "Excessive diarrhea is a sign of quinidine toxicity and may precede serious cardiac dysrhythmias.",
    "clinicalPearl": "GI symptoms are often the earliest warning sign of quinidine toxicity."
  },
  {
    "id": "rn-q-002",
    "scope": ["RN"],
    "medicationId": "rn-002",
    "medication": "Procainamide",
    "questionType": "select-all-that-apply",
    "stem": "Which findings suggest a potential adverse reaction to procainamide? (Select all that apply.)",
    "choices": [
      "Joint pain",
      "Butterfly-shaped facial rash",
      "Hypotension",
      "Bradycardia",
      "Dry cough"
    ],
    "correctAnswer": [
      "Joint pain",
      "Butterfly-shaped facial rash",
      "Hypotension"
    ],
    "rationale": "Procainamide can cause a lupus-like syndrome and hypotension.",
    "clinicalPearl": "Drug-induced lupus is a well-known complication of procainamide therapy."
  },
  {
    "id": "rn-q-003",
    "scope": ["RN"],
    "medicationId": "rn-003",
    "medication": "Lidocaine",
    "questionType": "multiple-choice",
    "stem": "Which assessment finding is most concerning in a patient receiving IV lidocaine?",
    "choices": [
      "Metallic taste",
      "Mild nausea",
      "Confusion and tremors",
      "Injection site discomfort"
    ],
    "correctAnswer": "Confusion and tremors",
    "rationale": "Neurologic symptoms indicate lidocaine toxicity and may precede seizures.",
    "clinicalPearl": "CNS toxicity occurs before cardiovascular collapse with lidocaine."
  },
  {
    "id": "rn-q-004",
    "scope": ["RN"],
    "medicationId": "rn-005",
    "medication": "Flecainide",
    "questionType": "multiple-choice",
    "stem": "Flecainide is contraindicated in patients with which condition?",
    "choices": [
      "Atrial fibrillation",
      "Structural heart disease",
      "Hypertension",
      "Sinus tachycardia"
    ],
    "correctAnswer": "Structural heart disease",
    "rationale": "Class IC agents increase mortality in patients with structural heart disease.",
    "clinicalPearl": "Class IC antidysrhythmics are powerful but dangerous in damaged myocardium."
  },
  {
    "id": "rn-q-005",
    "scope": ["RN"],
    "medicationId": "rn-007",
    "medication": "Esmolol",
    "questionType": "multiple-choice",
    "stem": "Why is esmolol preferred for short-term rate control in acute settings?",
    "choices": [
      "It has oral availability",
      "It has a long half-life",
      "It has a very short half-life",
      "It causes less hypotension than other beta-blockers"
    ],
    "correctAnswer": "It has a very short half-life",
    "rationale": "Esmolol’s rapid onset and short duration allow quick titration and discontinuation.",
    "clinicalPearl": "Esmolol is ideal when rapid beta-blockade reversal may be needed."
  },
  {
    "id": "rn-q-006",
    "scope": ["RN"],
    "medicationId": "rn-012",
    "medication": "Amiodarone",
    "questionType": "select-all-that-apply",
    "stem": "Which teaching points should be included for a patient starting amiodarone? (Select all that apply.)",
    "choices": [
      "Avoid grapefruit products",
      "Report vision changes",
      "Monitor for thyroid dysfunction",
      "Take medication with high-fat meals",
      "Expect urine discoloration"
    ],
    "correctAnswer": [
      "Avoid grapefruit products",
      "Report vision changes",
      "Monitor for thyroid dysfunction"
    ],
    "rationale": "Amiodarone affects thyroid, eyes, and has major CYP interactions with grapefruit.",
    "clinicalPearl": "Amiodarone affects multiple organ systems—ongoing monitoring is essential."
  },
  {
    "id": "rn-q-009",
    "scope": ["RN"],
    "medicationId": "rn-009",
    "medication": "Atenolol",
    "questionType": "multiple-choice",
    "stem": "Which assessment finding would require holding atenolol and notifying the provider?",
    "choices": [
      "Blood pressure 138/84 mmHg",
      "Heart rate 52 bpm",
      "Mild fatigue",
      "Occasional headache"
    ],
    "correctAnswer": "Heart rate 52 bpm",
    "rationale": "Atenolol can cause bradycardia; heart rates below 60 bpm warrant provider notification.",
    "clinicalPearl": "Always assess apical pulse before administering beta blockers."
  },
  {
    "id": "rn-q-010",
    "scope": ["RN"],
    "medicationId": "rn-010",
    "medication": "Propranolol",
    "questionType": "multiple-choice",
    "stem": "Why should propranolol be used cautiously in patients with asthma?",
    "choices": [
      "It increases mucus production",
      "It blocks beta-2 receptors causing bronchoconstriction",
      "It prolongs the QT interval",
      "It causes excessive sedation"
    ],
    "correctAnswer": "It blocks beta-2 receptors causing bronchoconstriction",
    "rationale": "Propranolol is nonselective and may worsen bronchospasm by blocking beta-2 receptors.",
    "clinicalPearl": "Nonselective beta blockers increase respiratory risk in asthma and COPD."
  },
  {
    "id": "rn-q-011",
    "scope": ["RN"],
    "medicationId": "rn-011",
    "medication": "Bisoprolol",
    "questionType": "multiple-choice",
    "stem": "Which patient teaching is most important for someone prescribed bisoprolol?",
    "choices": [
      "Limit potassium-rich foods",
      "Do not abruptly stop the medication",
      "Take the medication at bedtime only",
      "Expect increased appetite"
    ],
    "correctAnswer": "Do not abruptly stop the medication",
    "rationale": "Abrupt discontinuation of beta blockers may cause rebound tachycardia and hypertension.",
    "clinicalPearl": "Beta blockers should always be tapered, not stopped suddenly."
  },
  {
    "id": "rn-q-012",
    "scope": ["RN"],
    "medicationId": "rn-012",
    "medication": "Amiodarone",
    "questionType": "select-all-that-apply",
    "stem": "Which findings should be reported immediately in a patient taking amiodarone? (Select all that apply.)",
    "choices": [
      "Blurred vision",
      "Weight gain",
      "Shortness of breath",
      "Photosensitivity",
      "Dry skin"
    ],
    "correctAnswer": [
      "Blurred vision",
      "Shortness of breath"
    ],
    "rationale": "Amiodarone can cause pulmonary toxicity and ocular changes.",
    "clinicalPearl": "Amiodarone affects multiple organs—lungs, thyroid, liver, and eyes."
  },
  {
    "id": "rn-q-013",
    "scope": ["RN"],
    "medicationId": "rn-013",
    "medication": "Dronedarone",
    "questionType": "multiple-choice",
    "stem": "Which medication interaction is most concerning when administering dronedarone?",
    "choices": [
      "Acetaminophen",
      "Digoxin",
      "Ibuprofen",
      "Aspirin"
    ],
    "correctAnswer": "Digoxin",
    "rationale": "Dronedarone increases digoxin levels, raising the risk of toxicity.",
    "clinicalPearl": "Always review cardiac drug combinations for additive effects."
  },
  {
    "id": "rn-q-014",
    "scope": ["RN"],
    "medicationId": "rn-014",
    "medication": "Dofetilide",
    "questionType": "multiple-choice",
    "stem": "Why must dofetilide initiation occur in a monitored setting?",
    "choices": [
      "Risk of hypotension",
      "Risk of renal failure",
      "Risk of torsades de pointes",
      "Risk of severe bradycardia"
    ],
    "correctAnswer": "Risk of torsades de pointes",
    "rationale": "Dofetilide prolongs QT interval and may precipitate torsades de pointes.",
    "clinicalPearl": "QT monitoring is mandatory with Class III antiarrhythmics."
  },
  {
    "id": "rn-q-015",
    "scope": ["RN"],
    "medicationId": "rn-015",
    "medication": "Ibutilide",
    "questionType": "multiple-choice",
    "stem": "Which electrolyte abnormality increases the risk of ibutilide-induced dysrhythmias?",
    "choices": [
      "Hypernatremia",
      "Hypokalemia",
      "Hypercalcemia",
      "Hypermagnesemia"
    ],
    "correctAnswer": "Hypokalemia",
    "rationale": "Low potassium increases QT prolongation and torsades risk.",
    "clinicalPearl": "Correct electrolytes before administering QT-prolonging drugs."
  },
  {
    "id": "rn-q-016",
    "scope": ["RN"],
    "medicationId": "rn-016",
    "medication": "Sotalol",
    "questionType": "multiple-choice",
    "stem": "Which finding would contraindicate giving sotalol?",
    "choices": [
      "QTc interval of 480 ms",
      "Heart rate 72 bpm",
      "Blood pressure 130/80 mmHg",
      "Mild fatigue"
    ],
    "correctAnswer": "QTc interval of 480 ms",
    "rationale": "Sotalol prolongs QT and increases risk of torsades de pointes.",
    "clinicalPearl": "QTc > 440 ms significantly raises dysrhythmia risk."
  },
  {
    "id": "rn-q-017",
    "scope": ["RN"],
    "medicationId": "rn-017",
    "medication": "Diltiazem",
    "questionType": "multiple-choice",
    "stem": "Which condition would make diltiazem unsafe to administer?",
    "choices": [
      "Atrial fibrillation with RVR",
      "Sick sinus syndrome without pacemaker",
      "Hypertension",
      "Stable angina"
    ],
    "correctAnswer": "Sick sinus syndrome without pacemaker",
    "rationale": "Diltiazem suppresses AV node conduction and may cause severe bradycardia.",
    "clinicalPearl": "AV-node blockers require rhythm awareness."
  },
  {
    "id": "rn-q-018",
    "scope": ["RN"],
    "medicationId": "rn-018",
    "medication": "Verapamil",
    "questionType": "multiple-choice",
    "stem": "Which concurrent medication increases the risk of heart block when given with verapamil?",
    "choices": [
      "Acetaminophen",
      "Metoprolol",
      "Furosemide",
      "Potassium chloride"
    ],
    "correctAnswer": "Metoprolol",
    "rationale": "Combined beta blockers and calcium channel blockers can cause severe bradycardia and heart block.",
    "clinicalPearl": "Avoid stacking AV-node blocking agents unless closely monitored."
  }
]

